Advance Bioactive Materials-Cells UKM Research Group, Universiti Kebangsaan Malaysia, 43600 Bangi, Selangor, Malaysia
Questions about peptides
den Abeelen AS, Lagro J, van Beek AH, Claassen JA
Last reviewed: June 9, 2026 Last updated: June 9, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
For patients with a personal history of any cancer, even if treated, resolved and with all signs removed, this is generally an area of discussion that is longer and frequently requires an oncology clearance beforehand
The review follows a shift in oversight to potentially increase access to these substances